Design and Synthesis of New Withaferin A Inspired Hedgehog Pathway Inhibitors.

2-piperidine ethanol Hedgehog inhibitors Hedgehog signalling pathway natural products withaferin A

Journal

Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783

Informations de publication

Date de publication:
04 Jun 2021
Historique:
received: 26 02 2021
pubmed: 4 4 2021
medline: 10 6 2021
entrez: 3 4 2021
Statut: ppublish

Résumé

Withanolides constitute a well-known family of plant-based alkaloids characterised by widespread biological properties, including the ability of interfering with Hedgehog (Hh) signalling pathway. Following our interest in natural products and in anticancer compounds, we report here the synthesis of a new class of Hh signalling pathway inhibitors, inspired by withaferin A, the first isolated member of withanolides. The decoration of our scaffolds was rationally supported by in silico studies, while functional evaluation revealed promising candidates, confirming once again the importance of natural products as inspiration source for the discovery of novel bioactive compounds. A stereoselective approach, based on Brown chemistry, allowed the obtainment and the functional evaluation of the enantiopure hit compounds.

Identifiants

pubmed: 33811701
doi: 10.1002/chem.202100315
pmc: PMC8251939
doi:

Substances chimiques

Antineoplastic Agents 0
Hedgehog Proteins 0
Withanolides 0
withaferin A L6DO3QW4K5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8350-8357

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : Project 20175XBSX4_003

Informations de copyright

© 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.

Références

Angew Chem Int Ed Engl. 2015 May 4;54(19):5596-602
pubmed: 25736574
J Nat Prod. 2016 Mar 25;79(3):629-61
pubmed: 26852623
Curr Opin Drug Discov Devel. 2006 Nov;9(6):700-12
pubmed: 17117681
Science. 2013 Mar 1;339(6123):1077-80
pubmed: 23348505
Expert Opin Ther Pat. 2020 Apr;30(4):235-250
pubmed: 32070165
Curr Pharm Des. 2015;21(38):5547-57
pubmed: 26429713
Cancers (Basel). 2019 Oct 09;11(10):
pubmed: 31601026
J Comput Aided Mol Des. 2002 Jan;16(1):11-26
pubmed: 12197663
Development. 2016 Feb 1;143(3):367-72
pubmed: 26839340
Antioxidants (Basel). 2020 May 05;9(5):
pubmed: 32380762
Nature. 2000 Aug 31;406(6799):1005-9
pubmed: 10984056
Nature. 2013 May 16;497(7449):338-43
pubmed: 23636324
Nat Commun. 2014 Jul 10;5:4355
pubmed: 25008467
Science. 1997 Aug 22;277(5329):1109-13
pubmed: 9262482
Eur J Med Chem. 2018 Aug 5;156:554-562
pubmed: 30025349
Molecules. 2020 Feb 27;25(5):
pubmed: 32120931
J Med Chem. 2014 Apr 10;57(7):2851-63
pubmed: 24625088
Nature. 2016 Jul 28;535(7613):517-522
pubmed: 27437577
Bioorg Med Chem Lett. 2015 Sep 1;25(17):3541-4
pubmed: 26169123
Org Lett. 2004 Sep 16;6(19):3217-9
pubmed: 15355016
ACS Med Chem Lett. 2017 Aug 01;8(9):953-957
pubmed: 28947943
Cancers (Basel). 2015 Aug 11;7(3):1554-85
pubmed: 26270676
Nat Rev Cancer. 2008 Oct;8(10):743-54
pubmed: 18813320
Med Hypotheses. 2016 Jul;92:35-43
pubmed: 27241252
Clin Cancer Res. 2012 Sep 15;18(18):4883-8
pubmed: 22718857
Genes Dev. 2002 Nov 1;16(21):2743-8
pubmed: 12414725
Arch Toxicol. 2015 Feb;89(2):179-91
pubmed: 25559776
J Enzyme Inhib Med Chem. 2018 Dec;33(1):349-358
pubmed: 29338454
Biochem Pharmacol. 2010 Feb 15;79(4):542-51
pubmed: 19769945
Nat Chem Biol. 2015 Apr;11(4):246-55
pubmed: 25785427
Clin Cancer Res. 2010 Jun 15;16(12):3130-40
pubmed: 20530699
Expert Opin Ther Targets. 2020 Nov;24(11):1159-1181
pubmed: 32990091
Nat Med. 2013 Nov;19(11):1410-22
pubmed: 24202394
J Org Chem. 2013 Jan 4;78(1):42-7
pubmed: 22994627
Cell Death Dis. 2016 Sep 22;7(9):e2376
pubmed: 27899820
Cell. 1993 Dec 31;75(7):1417-30
pubmed: 7916661
Drug Discov Today. 2008 Oct;13(19-20):894-901
pubmed: 18691670
Bioorg Med Chem Lett. 2006 May 15;16(10):2603-7
pubmed: 16513346
Chempluschem. 2015 Jun;80(6):938-943
pubmed: 31973263
Drug Discov Today. 2014 Oct;19(10):1547-62
pubmed: 24819719
Chemistry. 2021 Jun 4;27(32):8350-8357
pubmed: 33811701
J Pathol. 2006 Jan;208(1):17-25
pubmed: 16294371
J Comput Aided Mol Des. 2012 Aug;26(8):897-906
pubmed: 22669221
Nat Rev Drug Discov. 2005 Mar;4(3):206-20
pubmed: 15729362
Eur J Pharmacol. 2008 Dec 3;599(1-3):11-7
pubmed: 18838070
Genes Dev. 2001 Dec 1;15(23):3059-87
pubmed: 11731473
Curr Opin Cell Biol. 2018 Apr;51:81-88
pubmed: 29268141
Cancer Lett. 2021 Feb 28;499:220-231
pubmed: 33249196
Science. 1996 Jun 14;272(5268):1668-71
pubmed: 8658145
Bioorg Med Chem Lett. 2018 Oct 15;28(19):3131-3140
pubmed: 30177379

Auteurs

Elisa Bonandi (E)

Department of Chemistry, Università degli Studi di Milano, Via Golgi 19, 20133, Milan, Italy.

Mattia Mori (M)

Department of Biotechnology, Chemistry and Pharmacy Università degli Studi di Siena, Via Aldo Moro 2, 53100, Siena, Italy.

Paola Infante (P)

Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy.

Irene Basili (I)

Department of Molecular Medicine, University La Sapienza, Roma, Viale Regina Elena 291, 00161, Roma, Italy.

Lucia Di Marcotullio (L)

Department of Molecular Medicine, University La Sapienza, Roma, Viale Regina Elena 291, 00161, Roma, Italy.
Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, University La Sapienza, Viale Regina Elena 291, 00161, Roma, Italy.

Andrea Calcaterra (A)

Department of Chemistry and Technology of Drugs, University La Sapienza, Roma, Piazzale Aldo Moro 5, 00185, Rome, Italy.

Federica Catti (F)

Arkansas State University, Campus Querétaro Carretera Estatal 100, km 17.5. C.P., 76270 Municipio de Colón, Querétaro, México.

Bruno Botta (B)

Department of Chemistry and Technology of Drugs, University La Sapienza, Roma, Piazzale Aldo Moro 5, 00185, Rome, Italy.

Daniele Passarella (D)

Department of Chemistry, Università degli Studi di Milano, Via Golgi 19, 20133, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Classifications MeSH